Skip to main content

Articles

Page 1 of 19

  1. Lower extremity deep vein thrombosis (LEDVT) is a common vascular disease, with its pathogenesis mainly involving inflammatory responses and oxidative stress. Liquiritin (LIQ) is a flavonoid that exhibits phar...

    Authors: Jiacheng Zhang, Nan Wang, Tianyou Xin, Xiaojun Zhu, Shengkun Lang and Xin Ge
    Citation: Thrombosis Journal 2025 23:51
    Content type: Research Published on:

  2. Thrombotic thrombocytopenic purpura (TTP) is an uncommon and life-threatening disorder caused by a deficiency of ADAMTS-13, and eventually leads to microangiopathic hemolytic anemia, severe thrombocytopenia, a...

    Authors: Geng-Hao Bai, Mei-Hwa Lin, Yu-Pei Chen, Tien-Jyun Chang and Sheng-Chieh Chou
    Citation: Thrombosis Journal 2025 23:50
    Content type: Case Report Published on:

  3. The National Early Warning Score (NEWS2) predicts clinical deterioration in hospitalized patients. Its role in pulmonary embolism (PE) risk stratification remains underexplored. This study assessed the associa...

    Authors: Anthony J. Weekes, Fernanda Calienescerpa, Kelly L. Goonan, Alexa L. Polzella, Melanie M. Hogg, Dalton Cox, Sean Flannigan, Emma Cruz, Halie A. O’Neill, Nathaniel S. O’Connell and Daniel R. Troha
    Citation: Thrombosis Journal 2025 23:49
    Content type: Research Published on:

  4. Venous thromboembolism (VTE) is a leading cause of maternal mortality, yet effective biomarkers for early prediction of adverse pregnancy outcomes remain limited. We aimed to investigate the association betwee...

    Authors: Rong Zhang, Xiao Mei Wang, Chao Yun Jiang, Tian Hong Cai, Jian Feng He, Kai Chen, Dian Xi Chen and Teng Hui Zhan
    Citation: Thrombosis Journal 2025 23:48
    Content type: Research Published on:

  5. Prognostic significance of stress hyperglycemia ratio (SHR) has not been well studied in patients with type 2 diabetes mellitus (T2DM) and acute coronary syndromes (ACS).

    Authors: Xiaoteng Ma, Huijun Chu, Yan Sun, Yujing Cheng, Dai Zhang, Lixia Yang, Zhijian Wang, Xiaoli Liu and Yujie Zhou
    Citation: Thrombosis Journal 2025 23:47
    Content type: Research Published on:

  6. Despite D-dimer to fibrinogen ratio (DFR) being reported as a prognostic factor for cerebral venous thrombosis (CVT), we note some concerns about the misused terminology (prognostic versus predictive), potenti...

    Authors: Minh-Hoang Tran and Kim-Huong Truong-Nguyen
    Citation: Thrombosis Journal 2025 23:46
    Content type: Correspondence Published on:

    The original article was published in Thrombosis Journal 2024 22:95

  7. Enoxaparin is commonly used for venous thromboembolism (VTE) prophylaxis in adult hospitalized patients. Although anti-Xa levels are inversely related to body weight, limited studies evaluated clinical outcome...

    Authors: Salam Ibrahim Abou Safrah, Mohamed Omar Saad, May Alasmar, Fatima Ashfaq Butt and Somaya Khaled Koraysh
    Citation: Thrombosis Journal 2025 23:45
    Content type: Research Published on:

  8. Several members of protein disulfide isomerase (PDI) family with the CXYC active motif such as PDI, ERp57, ERp72, ERp46, ERp5 and TMX1 have important roles in platelet functions and thrombosis. These members c...

    Authors: Xiaofeng Yan, Yishan Lu, Keyu Lv, Miao Jiang, Chao Fang, Yi Wu and Aizhen Yang
    Citation: Thrombosis Journal 2025 23:44
    Content type: Research Published on:

  10. An increased prevalence of PE has been found in patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD). Early identification of risk factors for the development of PE in patients wit...

    Authors: Mingzhu Li, Yeqian Jiang, Ying Xu and Qianbing Li
    Citation: Thrombosis Journal 2025 23:42
    Content type: Review Published on:

  11. Von Willebrand disease (VWD) is a hereditary bleeding disorder characterized by a quantitative or qualitative deficiency of von Willebrand factor (VWF). Pregnancy significantly impacts hemostasis, leading to a...

    Authors: Hamed Soleimani Samarkhazan, Mohammad Navid khaksari, Ali Rahmati, Mahsa Loran Esfahani, Amin Solouki and Mojtaba Aghaei
    Citation: Thrombosis Journal 2025 23:41
    Content type: Review Published on:

  12. This study investigated the diagnostic value of magnetic resonance angiography (MRA) combined with serum ischaemia-modifier albumin (IMA) testing in predicting secondary cerebral infarction (CI) following tran...

    Authors: Lige Liu, Qiuyue Yan, Jingyi Ai, Rudong Jiao and Meng Li
    Citation: Thrombosis Journal 2025 23:40
    Content type: Research Published on:

  14. Although ticagrelor is recommended as opposed to clopidogrel in antiplatelet strategy for patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention ...

    Authors: Can Zhou, Minghui Zhang, Zixu Zhao, Enze Li, Yichen Zhao, Wei Luo, Keyang Zheng, Yu Liu, Chengqian Yin, Xinyong Zhang, Hai Gao, Dong Zhao and Changsheng Ma
    Citation: Thrombosis Journal 2025 23:38
    Content type: Research Published on:

  15. Tranexamic acid (TXA) reduces mortality in severe trauma cases. However, the relationships between TXA administration and coagulation/fibrinolysis abnormalities are unclear. We performed a retrospective observ...

    Authors: Yuki Takahashi, Mineji Hayakawa, Yuki Itagaki, Kota Ono, Daisuke Kudo and Shigeki Kushimoto
    Citation: Thrombosis Journal 2025 23:37
    Content type: Research Published on:

  16. Edoxaban, a direct oral anticoagulant (DOAC), is a first-line treatment for venous thromboembolism (VTE) and the suppression of VTE recurrence. In patients with cancer, however, recurrent VTE after DOAC treatm...

    Authors: Masashi Yoshida, Kentaro Ejiri, Naoaki Matsuo, Takanori Naito, Kazuhiro Kuroda, Koji Tokioka, Kunihiko Hatanaka, Ryohei Fujimoto, Hidenaru Yamaoka, Yutaka Kajikawa, Kazuki Suruga, Hiroki Sugiyama, Tsuyoshi Miyaji, Yoshimasa Morimoto, Nobuhiro Okamura, Toshihiro Sarashina…
    Citation: Thrombosis Journal 2025 23:36
    Content type: Research Published on:

  18. Advances in hemophilia treatment have reduced bleeding episodes in patients with hemophilia (PWH) and improved their musculoskeletal prognosis; however, complete prevention of musculoskeletal disorders has not...

    Authors: Yosuke Uchihashi, Tatsuya Noda, Yusuke Inagaki, Kenichi Ogiwara, Yuya Mawarikado, Yuichi Nishioka, Tomoya Myojin, Kagehiro Amano, Akira Shirahata, Keiji Nogami, Akira Kido and Tomoaki Imamura
    Citation: Thrombosis Journal 2025 23:34
    Content type: Research Published on:

  19. Venous thromboembolism (VTE) is a rare complication following rhinoplasty surgery, with an occurrence rate generally estimated to be between 0.5% and 1%. In contrast, the occurrence rate of VTE in orthopedic s...

    Authors: Jie Chen, Jianfei Zhang, Xia Xiao, Yujun Tang, Hejin Huang, Wenwen Xi, Lina Liu, Zhengzhou Shen, Jianhua Tan and Feng Yang
    Citation: Thrombosis Journal 2025 23:33
    Content type: Research Published on:

  20. Tissue factor (TF)-rich cancer microvesicles are correlated with thrombosis risk. Intrinsic coagulation factors are also associated with the risk of thrombosis in cancer patients. This study explored the roles...

    Authors: Sheng-Chieh Chou, Shu-Lun Chang, Cheng-Yeh Yu, Chao-I Lin, Yen-Ting Chang, Li-Fu Chen, Jia-Yi Li, Chen‑Hsueh Pai, Shu-Rung Lin, Wern-Cherng Cheng, Chang-Tsu Yuan and Shu-Wha Lin
    Citation: Thrombosis Journal 2025 23:32
    Content type: Research Published on:

  21. Venous thromboembolism (VTE) is a common postoperative complication in oncologic surgery, closely associated with perioperative hypercoagulability. Thromboelastography (TEG) may be an effective method for moni...

    Authors: Songping Cui, Ruiheng Jiang, Jiaojie Zhao, Jing Wang, Bin Hu, Hui Li and Shuo Chen
    Citation: Thrombosis Journal 2025 23:31
    Content type: Research Published on:

  22. Treatment with combined oral contraceptives (COC) is associated with an increased risk of venous thromboembolism. Several changes of coagulant and anticoagulant factors induced by ethinyloestradiol during trea...

    Authors: Jesper Strandberg, Inger Lise Gade, Jette Nybo, Janus Nikolaj Laust Thomsen and Søren Risom Kristensen
    Citation: Thrombosis Journal 2025 23:30
    Content type: Research Published on:

  23. Investigations of the association between missense variants in the methylenetetrahydrofolate reductase (MTHFR) gene and thromboembolic diseases have been limited by small sample sizes. The effect of these variant...

    Authors: Iyas Daghlas, Mengmeng Wang and Dipender Gill
    Citation: Thrombosis Journal 2025 23:29
    Content type: Research Published on:

  24. Venous thromboembolism (VTE) is a grave medical condition characterized by the blockage of distant blood vessels due to blood clots or detached vessel wall fragments, leading to ischemia or necrosis of the aff...

    Authors: Yue Zhang and Rui Wang
    Citation: Thrombosis Journal 2025 23:28
    Content type: Research Published on:

  25. Deep vein thrombosis (DVT) is a prevalent complication associated with malignancy. Clinical use of thromboprophylaxis is recommended, however its usage is limited due to bleeding complications, more cost assoc...

    Authors: Budi Setiawan, Widi Budianto, Tri Wahyu Sukarnowati, Daniel Rizky, Eko Adhi Pangarsa, Damai Santosa, Aru Wisaksono Sudoyo, Tri Indah Winarni, Ignatius Riwanto, Rahajuningsih Dharma Setiabudy and Catharina Suharti
    Citation: Thrombosis Journal 2025 23:27
    Content type: Research Published on:

  26. Arterial thrombotic events are the leading causes of death worldwide, and the therapeutic effects of current antiplatelet drugs are not fully satisfactory. Oroxylin A (OroA), a flavone compound extracted from Scu...

    Authors: Yufei Chen, Yuan Lin, Jin Hong, Jiaorui Wang, Biling Li, Zixian Liu, Yongbo Ma, Xiaolan Sun, Shufang Wang, Mingjie Li, Meiling Wu, Deyu Fu, Jian Li, Mingzhu Wang and Liang Hu
    Citation: Thrombosis Journal 2025 23:26
    Content type: Research Published on:

  27. Patients with solid organ cancers are at increased risk of developing cancer-associated thrombosis (CAT), a complication driven by a complex interplay of patient-specific factors, cancer characteristics, and t...

    Authors: Lailatulema Abbas, Ibtisam Muhamad Nor, Fuad Ismail, Sivakumar Palaniappan, Guang Yong Chong, Sharifa Ezat Wan Puteh, Siti Afiqah Muhamad Jamil and Nor Rafeah Tumian
    Citation: Thrombosis Journal 2025 23:25
    Content type: Research Published on:

  29. Even with adherence to thromboprophylaxis recommended by guidelines, the incidence of deep vein thrombosis (DVT) remains high among patients with severe community-acquired pneumonia (SCAP). There is an urgent ...

    Authors: Na Cui, Jing Wang, Xiaokai Feng, Liming Zhang and Yuanhua Yang
    Citation: Thrombosis Journal 2025 23:23
    Content type: Research Published on:

  30. The location of thrombus in acute pulmonary embolism (PE) is a debatable prognostic factor. We compared the characteristics and outcomes of hospitalized patients with central versus peripheral PE.

    Authors: Hasan M. Al-Dorzi, Faisal M. Almutawa, Bader A. AlRuhaymi, Abdulaziz O. Alhusaini, Abdulelah M. Alnamlah, Abdullah M Bin Shaman, Mohamed M. Hegazy, Yahya A. Alayyafi, Moayad Alkhlewi, Ali A. Alaklabi and Yaseen M. Arabi
    Citation: Thrombosis Journal 2025 23:22
    Content type: Research Published on:

  31. Intravenous thrombolysis (IVT) with recombinant tissue plasminogen activator (rt-PA) is the preferred treatment for acute ischemic stroke (AIS). Nevertheless, only approximately half of patients undergoing IVT...

    Authors: Yayun Xu, Haixing Feng, Zhengzheng Huang, Yanlei Li, Feng Chi and Lijie Ren
    Citation: Thrombosis Journal 2025 23:21
    Content type: Research Published on:

  32. Direct oral anticoagulants (DOACs) are widely used as first-line agents in various clinical settings. However, there is very little evidence regarding their use in critically ill patients in the intensive care...

    Authors: Abdulmajeed M. Alshehri, Mohammed Alrashed, Mohammed Alzahrani, Abdulmajeed Alsuwaylihi, Abdulaziz Alarifi, Faris Althobiti and Majed S. Al Yami
    Citation: Thrombosis Journal 2025 23:20
    Content type: Research Published on:

  33. This study aimed to explore the efficacy of Prognostic Nutritional Index (PNI), Controlling Nutritional Status (CONUT), and Nutritional Risk Index (NRI) in predicting postthrombotic syndrome (PTS) in patients ...

    Authors: Shanhong Lin, Ning Zhu and Shengmin Zhang
    Citation: Thrombosis Journal 2025 23:19
    Content type: Research Published on:

  34. Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death in diabetes mellitus (DM) patients. Oxidative stress and inflammation are important pathological mechanisms affecting the occurrence...

    Authors: Xiaoqiong Lyu, Liping Chen and Wenbin Wang
    Citation: Thrombosis Journal 2025 23:18
    Content type: Research Published on:

  35. To explore the causal relationship between serum albumin and venous thromboembolism (VTE) comprises deep vein thrombosis (DVT) and its consequential condition, pulmonary embolism (PE), through Mendelian random...

    Authors: Xuemei Xia, Xin Tie, Maolin Hong and Wanhong Yin
    Citation: Thrombosis Journal 2025 23:17
    Content type: Research Published on:

  36. Vascular thiol isomerases (VTIs) encompass proteins such as protein disulfide isomerase (PDI), endoplasmic reticulum protein 5 (ERp5), ERp46, ERp57, ERp72, thioredoxin-related transmembrane protein 1 (TMX1), a...

    Authors: Longguang Jiang, Cai Yuan, Robert Flaumenhaft and Mingdong Huang
    Citation: Thrombosis Journal 2025 23:16
    Content type: Review Published on:

  37. Cerebral sinus thrombosis, which constitutes a small percentage of all strokes, usually affects young individuals and can lead to venous stroke. Ischemic and hemorrhagic Stroke are associated with Spreading De...

    Authors: Renan Sanchez-Porras, Francisco L. Ramírez-Cuapio, Mildred A. Gutiérrez-Herrera, Ángel Alberto Puig-Lagunes, Pablo Albiña-Palmarola, Juan M. López-Navarro, Marcos Alejandro Suárez-Gutiérrez, Roberto Díaz-Peregrino, Diego A. Sandoval-Lopez, Gregor Fischer, Farzam Vazifehdan, Johannes Woitzik and Edgar Santos
    Citation: Thrombosis Journal 2025 23:15
    Content type: Research Published on:

  39. To evaluate the comparative effectiveness of two distinct balloon pressure band compression regimens on the treatment outcomes for deep vein thrombosis (DVT) and venous blood flow velocity in the lower limbs o...

    Authors: Baihong Cui, Zhiyan Cao, Haiyan Gu, Jia Zhao, Jianan Zhou and Li Sun
    Citation: Thrombosis Journal 2025 23:13
    Content type: Research Published on:

  40. Total hip arthroplasty (THA) is classified as a high-risk surgery for venous thromboembolism (VTE) events, especially in elderly individuals and in cases of anemia. This study aims to uncover independent risk ...

    Authors: Yutai Li, Guowei Zeng, Weicong Yin, Shaowei Zheng, Luyuan Yang, Huangze Yan, Huikun Cao, Shoubin Huang, Guihua Liu and Chunhan Sun
    Citation: Thrombosis Journal 2025 23:12
    Content type: Research Published on:

  41. Venous thromboembolism (VTE) is a major, frequent, and potentially fatal health issue worldwide. Community-acquired pneumonia (CAP) is one of the leading causes of hospitalization and parapneumonic pleural eff...

    Authors: Xin-Yu Shi, Yi-Xiao Zhang, Feng-Shuang Yi, Shu-Feng Dong, Qing-Yu Chen, Xiao-Jing Jiao and Yuan-Hua Yang
    Citation: Thrombosis Journal 2025 23:11
    Content type: Research Published on:

  42. Although Ginkgo biloba extract (GBE) has been shown to be effective in treating acute ischemic stroke (AIS) in several clinical trials, concerns regarding adverse events, such as bleeding, have been raised. Th...

    Authors: Xiangqian Huang, Xiaoming Zhang, Jiahao Song, Duo Lan, Mengqi Wang, Xunming Ji, Da Zhou and Ran Meng
    Citation: Thrombosis Journal 2025 23:10
    Content type: Research Published on:

  43. Nephrotic syndrome (NS) is associated with an increased risk of venous thromboembolism (VTE). Anticoagulants are widely used in the prevention of VTE in NS patients. The use of direct oral anticoagulants (DOAC...

    Authors: Ahmed El-Bardissy, Mohamed Nabil Elshafei, Hebatullah Abdelgawad, Rana Mekkawi, Asma Eltahir, AbdulMoqeeth Mohammed, Ashour AM and Hazem Elewa
    Citation: Thrombosis Journal 2025 23:9
    Content type: Research Published on:

  44. Venous thromboembolism (VTE) is a common vascular disease with a significant global burden, influenced by multiple factors, such as genetic, environmental, and immune components. Immune responses and shifts in...

    Authors: Ning Qi, Zhuochen Lyu, Lu Huang, Yun Zhao, Wan Zhang, Xinfeng Zhou, Yang Zhang and Jiasen Cui
    Citation: Thrombosis Journal 2025 23:8
    Content type: Research Published on:

  45. Anticoagulation therapy is a critical component of post-transcatheter aortic valve implantation (TAVI) management, aimed at reducing the risk of thromboembolic events and mortality. This review examines the ef...

    Authors: Ravi Patel, Emmanuel Kokori, Gbolahan Olatunji, Israel Charles Abraham, Adeola Akinboade, Emmanuel Ababio Agyemang, Adetola Babalola and Nicholas Aderinto
    Citation: Thrombosis Journal 2025 23:7
    Content type: Review Published on:

  46. To investigate the association between inflammatory indices-systemic immune-inflammation index (SII), monocyte-lymphocyte ratio (MLR), neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and pre...

    Authors: Xiaojuan Xiong, Peng Hu, Ting Li, Shuang Yu and Qingxiang Mao
    Citation: Thrombosis Journal 2025 23:6
    Content type: Research Published on:

  48. Acute pulmonary embolism (PE) is a serious and potentially fatal condition that is relatively rare in the pediatric population. In patients presenting with massive/submassive PE, catheter-directed Therapy (CDT...

    Authors: Basel F. Alqeeq, Dina Essam Abo-elnour, Mohamed Rifai, Luis L. Gamboa, Ibrahim Qattea, Mohammed Hamzah, Khaled M. Al-Farawi, Alaa Ahmed Elshanbary, Ibrahim Kamal and Mohammed Alsabri
    Citation: Thrombosis Journal 2025 23:4
    Content type: Review Published on:
Submit manuscript

Official journal of

  • APSTH logo

  • Thrombosis Journal is the official journal of the Asian-Pacific Society on Thrombosis and Hemostasis.

Follow

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.6
    5-year Journal Impact Factor: 3.1
    Source Normalized Impact per Paper (SNIP): 0.653
    SCImago Journal Rank (SJR): 0.572

    Speed 2024
    Submission to first editorial decision (median days): 13
    Submission to acceptance (median days): 108

    Usage 2024
    Downloads: 622,602
    Altmetric mentions: 627

Thrombosis Journal

ISSN: 1477-9560

Contact us